Cite
HARVARD Citation
Golshan, M. et al. (2020). Early assessment with magnetic resonance imaging for prediction of pathologic response to neoadjuvant chemotherapy in triple-negative breast cancer: Results from the phase III BrighTNess trial. European journal of surgical oncology. 46 (2), pp. 223-228. [Online].